OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 73 filers reported holding OVID THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13,300 | -60.9% | 5,155 | -51.4% | 0.00% | – |
Q4 2021 | $34,000 | -42.4% | 10,604 | -39.5% | 0.00% | -100.0% |
Q3 2021 | $59,000 | -70.1% | 17,519 | -64.2% | 0.00% | -66.7% |
Q1 2021 | $197,000 | +77.5% | 48,891 | +153.2% | 0.00% | +50.0% |
Q3 2020 | $111,000 | -26.0% | 19,309 | -5.4% | 0.00% | -33.3% |
Q2 2020 | $150,000 | +38.9% | 20,417 | -21.4% | 0.00% | +50.0% |
Q4 2019 | $108,000 | +500.0% | 25,991 | +151.3% | 0.00% | +100.0% |
Q1 2019 | $18,000 | – | 10,343 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |